There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and several have been approved for emergency or full use on six continents. In the US, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Poll Finds Majority of New Jerseyans Give Negative Ratings to State and National Economy.
- New NJACTS Publication
- One Rule Change Would Help Tens of Thousands of New Jersey Families Pay for Childcare
- Advanced Models Offer Scientists a Promising Tool to Better Understand Brain Disorders
- NJIT Computing Professor Zhi Wei Named Fellow of AAAS, Follows IEEE Honor.
Categories
- Community (2,241)
- Covid (985)
- CTO Events (6)
- News (2,856)
- Pilots (21)